| scholarly article | Q13442814 |
| P50 | author | Eili Y. Klein | Q38804645 |
| P2093 | author name string | E Y Klein | |
| P2860 | cites work | Stage-specific sensitivity of Plasmodium falciparum to antifolates. | Q52263684 |
| Address in Pathology, ON CHEMIOTHERAPY: Delivered before the Seventeenth International Congress of Medicine | Q53461125 | ||
| Impact of chloroquine resistance on malaria mortality. | Q54121783 | ||
| A simple model of the build-up of resistance to mixtures of anti-malarial drugs. | Q54436068 | ||
| Multigenic drug resistance among inbred malaria parasites. | Q55668286 | ||
| Artesunate misuse and Plasmodium falciparum malaria in traveler returning from Africa | Q56773038 | ||
| The de novo selection of drug-resistant malaria parasites | Q73138568 | ||
| The duration of untreated or inadequately treated Plasmodium falciparum infections in the human host | Q76001016 | ||
| A new world malaria map: Plasmodium falciparum endemicity in 2010 | Q17485680 | ||
| Global malaria mortality between 1980 and 2010: a systematic analysis | Q20905423 | ||
| Artemisinin resistance: current status and scenarios for containment | Q21032505 | ||
| Review of the clinical pharmacokinetics of artesunate and its active metabolite dihydroartemisinin following intravenous, intramuscular, oral or rectal administration | Q21034080 | ||
| Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment | Q21090072 | ||
| Malaria infection increases attractiveness of humans to mosquitoes | Q21146092 | ||
| Antimalarial drug resistance | Q22061790 | ||
| Artemisinin Resistance in Plasmodium falciparum Malaria | Q22061852 | ||
| Evidence of Artemisinin-Resistant Malaria in Western Cambodia | Q22061854 | ||
| The role of human movement in the transmission of vector-borne pathogens | Q24290757 | ||
| Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study | Q24598695 | ||
| Assessment of the pharmacodynamic properties of antimalarial drugs in vivo | Q24670346 | ||
| Epidemiological models for the spread of anti-malarial resistance | Q24805506 | ||
| The unexpected importance of mosquito oviposition behaviour for malaria: non-productive larval habitats can be sources for malaria transmission | Q24814388 | ||
| Mosquito (Diptera: Culicidae) Dispersal--The Long and Short of it | Q26250218 | ||
| Potential impact of intermittent preventive treatment (IPT) on spread of drug-resistant malaria | Q28468762 | ||
| Genome-wide compensatory changes accompany drug- selected mutations in the Plasmodium falciparum crt gene | Q28472981 | ||
| Transmission intensity and drug resistance in malaria population dynamics: implications for climate change | Q28475943 | ||
| A model for the origins and spread of drug-resistant malaria | Q47845510 | ||
| Type II mefloquine resistance in Thailand | Q47972578 | ||
| The analysis of the sporozoite rate | Q47980663 | ||
| Superinfection and the evolution of resistance to antimalarial drugs. | Q51344705 | ||
| Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum | Q29615117 | ||
| Changing patterns of clinical malaria since 1965 among a tea estate population located in the Kenyan highlands | Q30611242 | ||
| Exploring 30 years of malaria case data in KwaZulu-Natal, South Africa: part II. The impact of non-climatic factors | Q33209853 | ||
| Making malaria-treatment policy in the face of drug resistance | Q33735489 | ||
| The biological cost of antibiotic resistance | Q33745219 | ||
| Delaying antimalarial drug resistance with combination chemotherapy | Q33852196 | ||
| Malaria-treatment policies: when and how should they be changed? | Q33856668 | ||
| The dynamics of mutations associated with anti-malarial drug resistance in Plasmodium falciparum | Q33897315 | ||
| Modelling a predictable disaster: the rise and spread of drug-resistantmalaria | Q33971977 | ||
| Concentrations of chloroquine and malaria parasites in blood in Nigerian children. | Q33979081 | ||
| Chloroquine-resistant malaria | Q34087800 | ||
| Mutations in cytochrome b resulting in atovaquone resistance are associated with loss of fitness in Plasmodium falciparum | Q34110755 | ||
| Epidemiology of the emergence and spread of drug-resistant falciparum malaria in South-East Asia and Australasia | Q34183109 | ||
| Ross, macdonald, and a theory for the dynamics and control of mosquito-transmitted pathogens | Q34229599 | ||
| Spread of chloroquine resistance in Plasmodium falciparum | Q34355288 | ||
| Heterogeneities in the transmission of infectious agents: implications for the design of control programs | Q34413014 | ||
| Intrahost modeling of artemisinin resistance in Plasmodium falciparum | Q34471842 | ||
| Will a global subsidy of new antimalarials delay the emergence of resistance and save lives? | Q34500215 | ||
| Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea | Q34509744 | ||
| Airport malaria: a review | Q34518921 | ||
| Invasion of Africa by a single pfcrt allele of South East Asian type | Q34602866 | ||
| The evolution of drug-resistant malaria: the role of drug elimination half-life | Q34655810 | ||
| A quantitative analysis of transmission efficiency versus intensity for malaria | Q34729685 | ||
| In vivo parasitological measures of artemisinin susceptibility | Q34921155 | ||
| The relationship between the volume of antimicrobial consumption in human communities and the frequency of resistance | Q34962080 | ||
| The entomological inoculation rate and Plasmodium falciparum infection in African children | Q35083314 | ||
| Antimalarial drug resistance and combination chemotherapy | Q35212414 | ||
| Host age as a determinant of naturally acquired immunity to Plasmodium falciparum | Q35846186 | ||
| Tolerance is the key to understanding antimalarial drug resistance. | Q36365898 | ||
| Clinical immunity to malaria | Q36412877 | ||
| P. falciparum dihydrofolate reductase and dihydropteroate synthase mutations: epidemiology and role in clinical resistance to antifolates | Q36648400 | ||
| High prevalence of mefloquine-resistant falciparum malaria in eastern Thailand | Q36669752 | ||
| Antimalarial drugs - what is in use and what is in the pipeline | Q37093752 | ||
| The global portfolio of new antimalarial medicines under development. | Q37464688 | ||
| How artemisinin-containing combination therapies slow the spread of antimalarial drug resistance | Q37802635 | ||
| pfmdr1 mutations associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum | Q38331106 | ||
| Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial | Q38410749 | ||
| Artemisinin resistance in Cambodia: a clinical trial designed to address an emerging problem in Southeast Asia | Q38498395 | ||
| Clinically immune hosts as a refuge for drug-sensitive malaria parasites | Q38793749 | ||
| Complex dynamics and stability of resistance to antimalarial drugs. | Q39055325 | ||
| Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for treatment of acute uncomplicated malaria in Thailand | Q39188543 | ||
| Mefloquine-resistant falciparum malaria on the Thai-Burmese border | Q39234433 | ||
| Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies | Q39363372 | ||
| Antifolate antimalarial resistance in southeast Africa: a population-based analysis | Q39408064 | ||
| Attributable fraction estimates and case definitions for malaria in endemic areas | Q39473645 | ||
| Plasmodium falciparum: in vitro studies of the pharmacodynamic properties of drugs used for the treatment of severe malaria | Q39517554 | ||
| Anopheles species of the mount Cameroon region: biting habits, feeding behaviour and entomological inoculation rates | Q39577909 | ||
| Artemisinin resistance--the clock is ticking | Q39589862 | ||
| Preventing antimalarial drug resistance through combinations | Q39589995 | ||
| Comparison of artemether and chloroquine for severe malaria in Gambian children | Q39590101 | ||
| High residual chloroquine blood levels in African children with severe malaria seeking healthcare | Q39591248 | ||
| Childhood mortality during and after hospitalization in western Kenya: effect of malaria treatment regimens. | Q39634098 | ||
| Return of chloroquine antimalarial efficacy in Malawi. | Q40465221 | ||
| Act now or later? Economics of malaria resistance | Q40486834 | ||
| Changes in the resistance of Plasmodium falciparum to chloroquine in Hainan, China | Q41001926 | ||
| Resistance of Plasmodium falciparum malaria to sulfadoxine-pyrimethamine ('Fansidar') in a refugee camp in Thailand | Q41925042 | ||
| Quantitative dissection of clone-specific growth rates in cultured malaria parasites | Q43077790 | ||
| Time of treatment influences the appearance of drug-resistant parasites in Plasmodium falciparum infections | Q43868276 | ||
| Differential attractiveness of isolated humans to mosquitoes in Tanzania | Q43954067 | ||
| Resistance of Plasmodium falciparum in Tanganyika to pyrimethamine administered at weekly intervals | Q43961974 | ||
| Modelling the development of resistance of Plasmodium falciparum to anti-malarial drugs | Q44143316 | ||
| Effects of treatment and drug resistance on the transmission dynamics of malaria in endemic areas | Q44144167 | ||
| Plasmodium invasion of mosquito cells: hawk or dove? | Q44145510 | ||
| The attraction of mosquitoes by human beings. | Q44150667 | ||
| A reaction-diffusion system modeling the spread of resistance to an antimalarial drug. | Q44151259 | ||
| Variation in attractiveness of human subjects to malaria mosquitoes (Diptera: Culicidae) in The Gambia | Q44172322 | ||
| Movement of Anopheles gambiae s.l. malaria vectors between villages in The Gambia | Q44172647 | ||
| A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites | Q44495547 | ||
| The analysis of infection rates in diseases in which superinfection occurs. | Q44824471 | ||
| Efficacy of rectal artesunate compared with parenteral quinine in initial treatment of moderately severe malaria in African children and adults: a randomised study. | Q44897666 | ||
| Artemisinin-resistant malaria in Asia. | Q45916491 | ||
| Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. | Q46833947 | ||
| Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance | Q46878245 | ||
| The evolution of multiple drug resistance in malaria parasites | Q47837189 | ||
| P433 | issue | 4 | |
| P921 | main subject | antimalarial | Q521616 |
| P304 | page(s) | 311-317 | |
| P577 | publication date | 2013-02-08 | |
| P1433 | published in | International Journal of Antimicrobial Agents | Q15724616 |
| P1476 | title | Antimalarial drug resistance: a review of the biology and strategies to delay emergence and spread | |
| P478 | volume | 41 |
| Q36921047 | A combined within-host and between-hosts modelling framework for the evolution of resistance to antimalarial drugs |
| Q28540567 | A population genetic model for the initial spread of partially resistant malaria parasites under anti-malarial combination therapy and weak intrahost competition |
| Q26753085 | Antimalarial drug resistance: An overview |
| Q34742823 | Antimicrobial peptides: a new class of antimalarial drugs? |
| Q92697422 | Attenuating the emergence of anti-fungal drug resistance by harnessing synthetic lethal interactions in a model organism |
| Q59330305 | Bayesian spatiotemporal analysis of malaria infection along an international border: Hlaingbwe Township in Myanmar and Tha-Song-Yang District in Thailand |
| Q41197352 | Catechin Isolated from Garcinia celebica Leaves Inhibit Plasmodium falciparum Growth through the Induction of Oxidative Stress |
| Q36906050 | Comparative assessment on the prevalence of mutations in the Plasmodium falciparum drug-resistant genes in two different ecotypes of Odisha state, India |
| Q47925010 | Development of sensitive direct chemiluminescent enzyme immunoassay for the determination of dihydroartemisinin in plasma |
| Q59792971 | Diagnostic accuracy of molecular methods for detecting markers of antimalarial drug resistance in clinical samples of Plasmodium falciparum: protocol for an update to a systematic review and meta-analysis |
| Q57004885 | Differential Transmission of Antiviral Drug-Resistant Chikungunya Viruses by Mosquitoes |
| Q30235317 | Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges |
| Q41703821 | Geographic-genetic analysis of Plasmodium falciparum parasite populations from surveys of primary school children in Western Kenya |
| Q36644848 | Imidazopyridazine Inhibitors of Plasmodium falciparum Calcium-Dependent Protein Kinase 1 Also Target Cyclic GMP-Dependent Protein Kinase and Heat Shock Protein 90 To Kill the Parasite at Different Stages of Intracellular Development |
| Q34591062 | Immunization against a merozoite sheddase promotes multiple invasion of red blood cells and attenuates Plasmodium infection in mice. |
| Q34438960 | In vitro and in vivo anti-malarial activity of tigecycline, a glycylcycline antibiotic, in combination with chloroquine |
| Q28552868 | Inhibition of an Erythrocyte Tyrosine Kinase with Imatinib Prevents Plasmodium falciparum Egress and Terminates Parasitemia |
| Q34156491 | Knockdown of mitogen-activated protein kinase (MAPK) signalling in the midgut of Anopheles stephensi mosquitoes using antisense morpholinos |
| Q30378608 | Making technological innovation work for sustainable development. |
| Q35799623 | Malaria ecology along the Thailand-Myanmar border |
| Q36793205 | Marine organism sulfated polysaccharides exhibiting significant antimalarial activity and inhibition of red blood cell invasion by Plasmodium |
| Q56785617 | Methylene blue for treating malaria |
| Q37414265 | Mutation tendency of mutator Plasmodium berghei with proofreading-deficient DNA polymerase δ |
| Q38260909 | New insight-guided approaches to detect, cure, prevent and eliminate malaria |
| Q90971436 | Novel Hydrophilic Riminophenazines as Potent Antiprotozoal Agents |
| Q44156122 | Novel strategies for Plasmodium-targeted drug delivery |
| Q30380109 | Parasites resistant to the antimalarial atovaquone fail to transmit by mosquitoes |
| Q27345457 | Picomolar Inhibition of Plasmepsin V, an Essential Malaria Protease, Achieved Exploiting the Prime Region |
| Q40331757 | Polyamidoamine nanoparticles as nanocarriers for the drug delivery to malaria parasite stages in the mosquito vector |
| Q86892951 | Predicting antiprotozoal activity of benzyl phenyl ether diamine derivatives through QSAR multi-target and molecular topology |
| Q59126454 | Predictive classifier models built from natural products with antimalarial bioactivity using machine learning approach |
| Q37635100 | Recasting the theory of mosquito-borne pathogen transmission dynamics and control |
| Q37633868 | The antimicrobial molecule trappin-2/elafin has anti-parasitic properties and is protective in vivo in a murine model of cerebral malaria |
| Q36332403 | The antiplasmodial and spleen protective role of crude Indigofera oblongifolia leaf extract traditionally used in the treatment of malaria in Saudi Arabia |
| Q37396654 | The impact of heterogeneous transmission on the establishment and spread of antimalarial drug resistance |
| Q33785170 | The role of extracellular vesicles in malaria biology and pathogenesis |
| Q37708532 | The ubiquitin system: an essential component to unlocking the secrets of malaria parasite biology |
| Q33636433 | Total synthesis of thiaplakortone a: derivatives as metabolically stable leads for the treatment of malaria |
| Q41588963 | Virtual-screening workflow tutorials and prospective results from the Teach-Discover-Treat competition 2014 against malaria |
| Q56341998 | Within-host competition can delay evolution of drug resistance in malaria |
Search more.